Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2023

Feb 22, 2023

61176_rns_2023-02-22_461dd629-fb48-40e0-b377-f2fb46dbae83.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [132 x 52] intentionally omitted <==

Biocon Limited

20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

February 22, 2023

To, To, The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code - 532523 Scrip Symbol - BIOCON

Subject: Redemption of Commercial Papers

Dear Sir/ Madam,

In terms of the SEBI Operational Circular No. SEBI/HO/DDHS/P/CIR/2021/613 dated 10th August, 2021 (as amended), for issue and listing of Non-convertible Securities, Securitised Debt Instruments, Security Receipts, Municipal Debt Securities and Commercial Paper, we wish to inform you that the Company has fulfilled its payment obligation and has fully redeemed the Commercial Papers (CPs) of Rs. 2,250 Crore as per following details:

ISIN MaturityDate Date of Payment
INE376G14016 February22,2023 February22,2023

We request you to take this on record.

Thanking You,

Yours faithfully,

For Biocon Limited

MAYA Digitally signed by MAYANK NK VERMA Date: 2023.02.22 VERMA 19:19:53 +05'30'


Mayank Verma Company Secretary and Compliance Officer Membership No.: ACS 18776